TTOOT2 Biosystems, Inc.

Nasdaq t2biosystems.com


$ 3.21 $ 0.21 (7 %)    

Thursday, 02-May-2024 10:30:52 EDT
QQQ $ 424.55 $ -0.69 (-0.16 %)
DIA $ 380.63 $ -0.89 (-0.23 %)
SPY $ 502.73 $ -1.67 (-0.33 %)
TLT $ 88.59 $ 0.38 (0.43 %)
GLD $ 212.81 $ 0.35 (0.16 %)
$ 3
$ 3.16
$ 0.00 x 0
$ 0.00 x 0
$ 3.16 - $ 3.26
$ 2.60 - $ 70.00
507,317
na
7.83M
$ 1.28
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-01-2024 12-31-2023 10-K
2 11-14-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 05-22-2023 03-31-2023 10-Q
5 03-31-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-23-2022 12-31-2021 10-K
10 11-04-2021 09-30-2021 10-Q
11 08-09-2021 06-30-2021 10-Q
12 05-13-2021 03-31-2021 10-Q
13 03-31-2021 12-31-2020 10-K
14 11-05-2020 09-30-2020 10-Q
15 08-12-2020 06-30-2020 10-Q
16 05-11-2020 03-31-2020 10-Q
17 03-16-2020 12-31-2019 10-K
18 11-18-2019 09-30-2019 10-Q
19 08-02-2019 06-30-2019 10-Q
20 05-10-2019 03-31-2019 10-Q
21 03-14-2019 12-31-2018 10-K
22 11-01-2018 09-30-2018 10-Q
23 08-02-2018 06-30-2018 10-Q
24 05-08-2018 03-31-2018 10-Q
25 03-19-2018 12-31-2017 10-K
26 11-03-2017 09-30-2017 10-Q
27 08-04-2017 06-30-2017 10-Q
28 05-08-2017 03-31-2017 10-Q
29 03-15-2017 12-31-2016 10-K
30 11-08-2016 09-30-2016 10-Q
31 08-08-2016 06-30-2016 10-Q
32 05-09-2016 03-31-2016 10-Q
33 03-09-2016 12-31-2015 10-K
34 11-04-2015 09-30-2015 10-Q
35 08-05-2015 06-30-2015 10-Q
36 05-06-2015 03-31-2015 10-Q
37 03-04-2015 12-31-2014 10-K
38 11-05-2014 09-30-2014 10-Q
39 09-19-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 canaccord-genuity-maintains-hold-on-t2-biosystems-lowers-price-target-to-3

Canaccord Genuity analyst Kyle Mikson maintains T2 Biosystems (NASDAQ:TTOO) with a Hold and lowers the price target from $12...

 t2-biosystems-receives-notice-of-allowance-for-us-patent-titled-methods-and-systems-for-amplification-in-complex-samples-including-diagnostic-and-therapeutics-methods-for-pathogens-in-whole-blood

https://t.co/156OpGGCCy https://t.co/SCcZwLnY0d

 why-riot-platforms-shares-are-trading-higher-here-are-20-stocks-moving-premarket

Shares of Riot Platforms, Inc. (NASDAQ:RIOT) rose sharply in today's pre-market trading amid a rise in Bitcoin. Bitcoin ...

 t2-biosystems-announces-new-publication-highlighting-the-clinical-benefits-and-performance-of-the-t2resistance-panel

T2 Biosystems, Inc. (NASDAQ:TTOO) (the "Company"), a leader in the rapid detection of sepsis-causing pathogens and anti...

 t2-biosystems-receives-extension-to-comply-with-nasdaq-listing-requirement

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...

 t2-biosystems-announces-preliminary-q4-revenue-of-17m-vs-24m-est-fy23-revenue-of-72m-vs-79m-est-fy24-revenue-of-10m-11m-vs-108m-est

T2 Biosystems, Inc. (NASDAQ:TTOO) (the "Company"), a leader in the rapid detection of sepsis-causing pathogens and anti...

 t2-biosystems-announces-agreement-with-crg-for-the-conversion-of-15m-of-crg-term-loan-into-equity

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...

 t2-biosystems-announces-commercial-expansion-through-distributors-in-europe-and-asia

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, ...

 earnings-scheduled-for-february-15-2024

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on rev...

 why-big-lots-shares-are-trading-lower-by-around-31-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Big Lots, Inc. (NYSE: BIG) fell sharply during Monday’s session after the company reported preliminary fourth-quarte...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION